MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson’s disease mouse model

    W. Jang, H-T. Kim (Seoul, Republic of Korea)

  • Transient orthostatic blood pressure changes in Parkinson’s Disease: impact on falls, syncope and orthostatic intolerance

    A. Fanciulli, N. Campese, G. Goebel, J. Ndayisaba, S. Eschlboeck, C. Kaindlstorfer, C. Raccagni, R. Granata, U. Bonuccelli, R. Ceravolo, W. Poewe, G. Wenning (Innsbruck, Austria)

  • Translating Preclinical Data to a Human Equivalent Dose for AMT-130 AAV Gene Therapy for Early Manifest Huntington’s Disease

    M. Evers, M. de Haan, A. Valles-Sanchez, E. Sawyer, S. Gill, R. Roos, S. van Deventer, P. Konstantinova, J. Higgins (Amsterdam, Netherlands)

  • Translation of a subject-specific stereotaxic platform to a large animal deep brain stimulation research models

    F. Paiva, B. Campbell, A. Martin, L. Frizon, A. Maldonado, A. Machado, K. Baker (Cleveland, OH, USA)

  • Translation, validation, diagnostic accuracy and reliability of a Parkinson´s disease screening questionnaire in three countries in Africa: A progress report and preliminary data

    NU. Okubadejo, A. Shalash, J. Doumbe, C. Tanner, R. Walker, C. Dotchin, OP. Agabi, E. Hamid, A. Helmi, H. Elrassas, T. Rushdi, O. Ojo, O. Oguntunde, S. Calvo, L. Aguado, E. Cubo (Burgos, Spain)

  • Treating Depression in Parkinson’s Disease: a Systematic Literature Review

    C. Farrell, T. Yousaf, M. Politis (London, United Kingdom)

  • Treatment approaches for infection following DBS

    F. Yuzbasi, H. Kaptan (Izmir, Turkey)

  • Treatment monitoring using objective and frequent digital testing in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial

    J. Wang, C. Battioui, Y. Li, A. Calvin, L. Wu, A. Romano, B. Miller (Indianapolis, IN, USA)

  • Treatment of dopaminergic augmented RLS with Ecopipam, A D1 specific antagonist: an exploratory placebo controlled cross-over trial

    O. Titlayo, W. Ondo (Houston, TX, USA)

  • Treatment of subcutaneous nodules after subcutaneous infusion of apomorphine

    RWK. Borgemeester, GFH. Diercks, T. van Laar (Groningen, Netherlands)

  • « Previous Page
  • 1
  • …
  • 205
  • 206
  • 207
  • 208
  • 209
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley